Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Opus Genetics, Inc. has filed 1,029 SEC EDGAR filings since 29 Apr 2003

SEC filing history

Showing 676-700 of 835 matching filings.

Per page
25
Current page
28
4

FORM 4

Filing date
12 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2014
Reporting date
18 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Dec 2014
Reporting date
02 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Dec 2014
Reporting date
02 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 12-2-2014

Filing date
03 Dec 2014
Reporting date
02 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2014

Filing date
12 Nov 2014
Reporting date
30 Sep 2014
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 10-1-2014

Filing date
03 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Sep 2014
Reporting date
04 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2014

Filing date
13 Aug 2014
Reporting date
30 Jun 2014
Next action
Verify source filing
EFFECT File 333-196255

EFFECT filing

Filing date
26 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-196255

REXAHN PHARMACEUTICALS, INC S-3/A 6-18-2014

Filing date
18 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 6-9-2014

Filing date
09 Jun 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-196255

REXAHN PHARMACEUTICALS INC S-3 5-23-2014

Filing date
23 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2014

Filing date
14 May 2014
Reporting date
31 Mar 2014
Next action
Verify source filing
ARS File 001-34079

AUTO-GENERATED PAPER DOCUMENT

Filing date
30 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .